ChartRow logo
ETON
$50.19+1.97%
as of close, Oct 20, 2026
☾ AH $50.19 +1.97%
PeersMRNALLYMDTUNHJNJTMO
Share this page

Eton Pharmaceuticals Inc. trailing returns

How Eton Pharmaceuticals Inc. (ETON) has performed over the last day, week, month and year, over 5 years, and since inception, through October 20, 2026 — price return and dividends side by side, with the worst drop inside each window.

Trailing returns by period#

To 2026-10-20. Price return + dividends = total return. Per year (CAGR) for windows of a year or more, with the cumulative total return beneath. Worst drop: the deepest fall in the price from a high inside the window, and when it bottomed.

PeriodPriceDivsTotalWorst drop
1 day+2.0%+0.0%+2.0%—
5 days-5.9%+0.0%-5.9%-7.7%Oct 19
1 month-9.6%+0.0%-9.6%-17.3%Oct 19
YTD+196.8%+0.0%+196.8%-23.6%Oct 19
1 year+172.8%+0.0%+172.8%-25.5%Feb 2026
5 years+55.6%+0.0%+55.6%+810.9%-69.3%Oct 2022
Since inception (2018)+30.0%+0.0%+30.0%+703.0%-79.9%Oct 2022

Growth of ETON#

Actual level with dividends reinvested (solid); dashed lines are each window's constant-rate path from start to today.

  • 5 years+55.6%/year · +810.9%

Methodology#

Trailing returns measure from the closest close about N years before the latest close (2026-10-20). Cumulative return is the total change over the window; annualized return is the compound annual growth rate (CAGR), shown for windows of a year or more. Price return is the change in ETON's closing price; total return reinvests dividends (from its split- and dividend-adjusted closes); the dividends column is the difference between the two. The worst drop is the largest fall in the closing price from a high to a later low inside the window, the way a drawdown is usually quoted. See the year-by-year returns for the calendar breakdown. Past performance does not predict future returns; not investment advice.

FAQ#

What is Eton Pharmaceuticals Inc.'s return since inception?
Since 2018, Eton Pharmaceuticals Inc. (ETON) has compounded at about +30.0% a year — +703.0% in total.

More on Eton Pharmaceuticals Inc.